CS logo
small CS logo
Hospital Wetzler

Wetzlar, Germany
Hospital in Wetzlar, Hessen
Forsthausstraße 1, 35578 Wetzlar

About Hospital Wetzler


"Wir begrüßen die Möglichkeit, Bewertungen über unser Unternehmen abgeben zu können. Leider können wir an dieser Stelle nicht auf Ihre Bewertungen eingehen. Bitte wenden Sie sich direkt an unser Qualitätsmanagement unter Tel. 06441 79-2021. Vielen Dank."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
3
Celgene
1
IlluminOss Medical, Inc.
1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
1
Pfizer
1
Total Rows: 5

Clinical Trials at Hospital Wetzler


During the past decade, Hospital Wetzler conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100110000111100000000000000Started TrialsCompleted Trails201520162017201820192020202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
A Safety and Efficacy Study of the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
2015-02-01
2017-06-01
Completed
14
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
2017-03-31
2026-01-13
Active, not recruiting
911
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
2020-10-13
2028-04-03
Recruiting
1,900
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
2021-08-09
2025-09-09
Recruiting
400

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Wetzler" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "Celgene" with 1 trials sponsored, "IlluminOss Medical, Inc." with 1 trials sponsored, "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Wetzler" #1 collaborator was "Merck Healthcare Germany GmbH, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman High-GradeNon-Hodgkin'sLymphoma StudyGroup: 3German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 3Celgene: 1Celgene: 1IlluminOss Medical, Inc.: 1IlluminOss Medical, Inc.: 1Merck Healthcare KGaA,Darmstadt, Germany,an affiliate of MerckKGaA, Darmstadt,Germany: 1Merck Healthcare KGaA,Darmstadt, Germany,an affiliate of MerckKGaA, Darmstadt,Germany: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsMerck HealthcareGermany GmbH, anaffiliate of Merck KGaA,Darmstadt, Germany: 1Merck HealthcareGermany GmbH, anaffiliate of Merck KGaA,Darmstadt, Germany: 1

Clinical Trials Conditions at Hospital Wetzler


According to Clinical.Site data, the most researched conditions in "Hospital Wetzler" are "Lymphoma" (3 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Humerus Pathological Fracture" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hospital Wetzler" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Wetzler


Most popular intervention types in "Hospital Wetzler" are "Drug" (5 trials), "Biological" (3 trials), "Radiation" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Wetzler


The vast majority of trials in "Hospital Wetzler" are 7 trials for "All" genders.

Clinical Trials Status at Hospital Wetzler


Currently, there are NaN active trials in "Hospital Wetzler". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Wetzler, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Wetzler, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1